Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease-Reference-Cited by-同舟云学术

Comparative clinical study evaluating the effect of adding Vildagliptin versus Glimepiride to ongoing Metformin therapy on diabetic patients with symptomatic coronary artery disease

Published:2020-12 Issue: Volume:170 Page:108473
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Werida Rehab,Kabel Mahmoud,Omran Gamal,Shokry Ahmed,Mostafa Tarek

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference50 articles.

1. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes;Holman;N Engl J Med.,2008

2. Atherosclerosis–an inflammatory disease;Ross;N Engl J Med,1999

3. Glimepiride: evidence-based facts, trends, and observations (GIFTS);Basit;Vasc Health Risk Manag.,2012

4. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study;Matthews;Diabetes Obes Metab.,2010

5. Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure;Yin;Cardiovasc Diabetol.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial;Perspectives in Clinical Research;2024-07-10

2. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology;Biomedicines;2022-08-19

3. Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging;Frontiers in Endocrinology;2021-08-17